ANGIOTENSIN RECEPTOR BLOCKERS AND ALDOSTERONE ANTAGONISTS IN CHRONIC HEART FAILURE

This publication has 29 references indexed in Scilit:

• Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure
  Journal of Cardiac Failure, 1999
• Rate and extent of left ventricular hypertrophy regression: a comparison of angiotensin II blockade with irbesartan and beta-blockade
  Journal of the American College of Cardiology, 1998
• Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
  The American Journal of Cardiology, 1995
• Losartan in Heart Failure
  Circulation, 1995
• Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling.
  Hypertension, 1994
• Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.
  Circulation, 1993
• Anti-Aldosterone Treatment and the Prevention of Myocardial Fibrosis in Primary and Secondary Hyperaldosteronism
  Journal of Molecular and Cellular Cardiology, 1993
• Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts
  Trends in Cardiovascular Medicine, 1993
• Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
  Circulation, 1990
• Ectopic arrhytmia provoking action of aldosterone
  Life Sciences, 1962